Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Rescinnamine
Homo sapiens
Drug Action Pathway
Rescinnamine is an angiotensin-converting enzyme (ACE) inhibitor for the conversion of angiotensin I into angiotensin II. Angiotensin II is a critical circulating peptide hormone that has powerful vasoconstrictive effects and increases blood pressure. Rescinnamine is used to treat hypertension and high blood pressure as it decreases blood pressure. Rescinnamine is an alkaloid from Rauwolfia serpintina which travels in the blood to inhibit ACE which is from the lungs. Angiotensin has many vasoconstrictive effects by binding to angiotensin II type 1 receptor (AT1) in blood vessels, kidneys, hypothalamus, and posterior pituitary. In blood vessels, AT1 receptors cause vasoconstriction in the tunica media layer of smooth muscle surrounding blood vessels increasing blood pressure. Less angiotensin II that is circulating lowers the constriction of these blood vessels. AT1 receptors in the kidney are responsible for the production of aldosterone which increases salt and water retention which increases blood volume. Less angiotensin II reduces aldosterone production allowing water retention to not increase. AT1 receptors in the hypothalamus are on astrocytes which inhibit the excitatory amino acid transporter 3 from up-taking glutamate back into astrocytes. Glutamate is responsible for the activation of NMDA receptors on paraventricular nucleus neurons (PVN neurons) that lead to thirst sensation. Since angiotensin II levels are lowered, the inhibition of the uptake transporter is not limited decreasing the amount of glutamate activating NMDA on PVN neurons that make the individual crave drinking less. This lowers the blood volume as well. Lastly, the AT1 receptors on posterior pituitary gland are responsible for the release of vasopressin. Vasopressin is an anti-diuretic hormone that cases water reabsorption in the kidney as well as causing smooth muscle contraction in blood vessels increasing blood pressure. Less angiotensin II activating vasopressin release inhibits blood pressure from increasing. Overall, Rescinnamine inhibits the conversion of angiotensin I into angiotensin II, a powerful vasoconstrictor and mediator of high blood pressure so decreasing levels of angiotensin will help reduce blood pressure from climbing in individuals.
References
Rescinnamine References
National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 5280954, Rescinnamine. Retrieved January 13, 2021 from https://pubchem.ncbi.nlm.nih.gov/compound/Rescinnamine.
Misra, N., Luthra, R., Singh, K. L., & Kumar, S. (1999). Recent Advances in Biosynthesis of Alkaloids. Comprehensive Natural Products Chemistry, 25-59. doi:10.1016/b978-0-08-091283-7.00127-2
Mukherjee, P. K. (2019). Bioactive Phytocomponents and Their Analysis. Quality Control and Evaluation of Herbal Drugs, 237-328. doi:10.1016/b978-0-12-813374-3.00007-7
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings